Our study reveals a more complex picture in cancer, where chromosomal gains containing various splicing factors (1q gain: SF3B4, PRPF3, 2q gain: CWC22, SF3B1) and other NMD-related genes are associated with reduced NMD efficiency. The gene discussed is CWC22; the disease is cancer.